|
Volumn 43, Issue 1, 2008, Pages 63-70
|
Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
a a a a a a a b a a c a |
Author keywords
BCAA; Compensated liver cirrhosis; HCV; Hepatocellular carcinoma
|
Indexed keywords
ALBUMIN;
BRANCHED CHAIN AMINO ACID;
GLYCYRRHIZIC ACID;
INTERFERON;
ISOLEUCINE;
LEUCINE;
TK 98;
UNCLASSIFIED DRUG;
URSODEOXYCHOLIC ACID;
VALINE;
ADULT;
AGED;
ALBUMIN BLOOD LEVEL;
ARTICLE;
ASCITES;
CANCER INCIDENCE;
CLINICAL TRIAL;
CONSTRICTIVE PERICARDITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFECT;
EDEMA;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEPATIC ENCEPHALOPATHY;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INHIBITION KINETICS;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MALE;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
AGED;
AMINO ACIDS, BRANCHED-CHAIN;
CARCINOMA, HEPATOCELLULAR;
DISEASE PROGRESSION;
DNA, VIRAL;
FEMALE;
FOLLOW-UP STUDIES;
HEPACIVIRUS;
HEPATITIS C ANTIBODIES;
HEPATITIS C, CHRONIC;
HUMANS;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
SERUM ALBUMIN;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 40149083901
PISSN: 09441174
EISSN: 14355922
Source Type: Journal
DOI: 10.1007/s00535-007-2122-0 Document Type: Article |
Times cited : (34)
|
References (26)
|